The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trialsMark Haas, Michael Mengel, Alexandre Loupy et al.|American Journal of Transplantation|2017Cited by 1k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejectionAlexandre Loupy, Michael Mengel, Mark Haas et al.|American Journal of Transplantation|2020Cited by 809
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular PathologyAlexandre Loupy, Michael Mengel, Mark Haas et al.|American Journal of Transplantation|2016Cited by 625
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathiesGina A. Montealegre Sanchez, Jonathan Janes, Jason Dare et al.|Journal of Clinical Investigation|2018Cited by 519